Hap Trading, LLC Exelixis, Inc. Put Options Transaction History

Hap Trading, LLC

7 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q4 2023 Feb 14, 2024	BUY	$19.25 - $24.13 $1.94 Million - $2.43 Million	100,900 New	100,900 $527,000
Q3 2020 Nov 13, 2020	BUY	$20.67 - $26.94 $14,469 - $18,858	700 Added 5.11%	14,400 $12,000
Q2 2019 Aug 14, 2019	SELL	$18.93 - $24.75 $98,436 - $128,700	-5,200 Reduced 27.51%	13,700 $16,000
Q1 2019 May 10, 2019	SELL	$19.6 - $24.76 $962,360 - $1.22 Million	-49,100 Reduced 72.21%	18,900 $21,000
Q4 2018 Feb 12, 2019	BUY	$13.65 - $21.8 $928,200 - $1.48 Million	68,000 New	68,000 $34,000
Q2 2018 Aug 13, 2018	SELL	$18.56 - $22.45 $1.6 Million - $1.93 Million	-86,000 Closed	0 $0
Q1 2018 May 11, 2018	BUY	$22.15 - $31.89 $1.9 Million - $2.74 Million	86,000 New	86,000 $321,000

501

244M

2.54M

2.29M

Ticker EXEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 321,832,000
Market Cap $11.5B
Description
Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Hap Trading, LLC with notifications on news.